Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roger Cady

Showing results (61-70 of 98) with videos related to

Pageof 10
Sort By:
The Journal of Headache and Pain|July 28, 2022
Optimization of acute medication use following eptinezumab initiation during a migraine attack: post hoc analysis of the RELIEF studyRoger Cady, Richard B Lipton, Dawn C Buse, et al.
Headache|May 7, 2022
Likelihood of response with subsequent dosing for patients with migraine and initial suboptimal response with eptinezumab: A post hoc analysis of two placebo-controlled randomized clinical trialsJack D Schim, Carlton Anderson, Elizabeth Brunner, et al.
Headache|May 31, 2006
Efficacy of Rizatriptan 10 mg administered early in a migraine attackRoger Cady, Vincent Martin, Alexander Mauskop, et al.
Neurology|January 23, 2015
Ineffective acute treatment of episodic migraine is associated with new-onset chronic migraineRichard B Lipton, Kristina M Fanning, Daniel Serrano, et al.
Headache|March 19, 2010
Predictability of future attacks by migraineurs: a prospective observational studyX Henry Hu, Wendy Golden, Susan C Bolge, et al.
Headache|May 16, 2007
Can migraineurs accurately identify their headaches as "migraine" at attack onset?Daisy S Ng-Mak, Roger Cady, Ya-Ting Chen, et al.
Headache|December 8, 2019
Content Validity of HIT-6 as a Measure of Headache Impact in People With Migraine: A Narrative ReviewCarrie R Houts, R J Wirth, James S McGinley, et al.
Clinical Therapeutics|February 8, 2022
Impact of Baseline Characteristics on the Efficacy and Safety of Eptinezumab in Patients With Migraine: Subgroup Analyses of PROMISE-1 and PROMISE-2Vincent Martin, A Jim Nagy, Marina Janelidze, et al.
The Journal of Headache and Pain|February 26, 2024
Harris Poll Migraine Report Card: population-based examination of high-frequency headache/migraine and acute medication overuseAmaal J Starling, Roger Cady, Dawn C Buse, et al.
Cephalalgia : an International Journal of Headache|August 10, 2014
Randomized controlled trial of the orexin receptor antagonist filorexant for migraine prophylaxisAlmira Chabi, Ying Zhang, Saheeda Jackson, et al.
Pageof 10

Showing results (61-70 of 98) with videos related to

Sort By:
Pageof 10
The Journal of Headache and Pain|July 28, 2022
Optimization of acute medication use following eptinezumab initiation during a migraine attack: post hoc analysis of the RELIEF studyRoger Cady, Richard B Lipton, Dawn C Buse, et al.
Headache|May 7, 2022
Likelihood of response with subsequent dosing for patients with migraine and initial suboptimal response with eptinezumab: A post hoc analysis of two placebo-controlled randomized clinical trialsJack D Schim, Carlton Anderson, Elizabeth Brunner, et al.
Headache|May 31, 2006
Efficacy of Rizatriptan 10 mg administered early in a migraine attackRoger Cady, Vincent Martin, Alexander Mauskop, et al.
Neurology|January 23, 2015
Ineffective acute treatment of episodic migraine is associated with new-onset chronic migraineRichard B Lipton, Kristina M Fanning, Daniel Serrano, et al.
Headache|March 19, 2010
Predictability of future attacks by migraineurs: a prospective observational studyX Henry Hu, Wendy Golden, Susan C Bolge, et al.
Headache|May 16, 2007
Can migraineurs accurately identify their headaches as "migraine" at attack onset?Daisy S Ng-Mak, Roger Cady, Ya-Ting Chen, et al.
Headache|December 8, 2019
Content Validity of HIT-6 as a Measure of Headache Impact in People With Migraine: A Narrative ReviewCarrie R Houts, R J Wirth, James S McGinley, et al.
Clinical Therapeutics|February 8, 2022
Impact of Baseline Characteristics on the Efficacy and Safety of Eptinezumab in Patients With Migraine: Subgroup Analyses of PROMISE-1 and PROMISE-2Vincent Martin, A Jim Nagy, Marina Janelidze, et al.
The Journal of Headache and Pain|February 26, 2024
Harris Poll Migraine Report Card: population-based examination of high-frequency headache/migraine and acute medication overuseAmaal J Starling, Roger Cady, Dawn C Buse, et al.
Cephalalgia : an International Journal of Headache|August 10, 2014
Randomized controlled trial of the orexin receptor antagonist filorexant for migraine prophylaxisAlmira Chabi, Ying Zhang, Saheeda Jackson, et al.
Pageof 10